Feasibility of a Physical Therapy Intervention on Older Adults With Hyperkyphosis or Forward Head Posture

Feasibility of a Post-Hospitalization PT Intervention in Patients With Pneumonia

The original intent was to use a manual therapy and therapeutic exercise intervention with older patients with pneumonia post-hospitalization. It was hypothesized that the physical therapy intervention would have a positive impact on posture, physical function, pulmonary function, gait, quality of life, and ultimately readmission. This patient population was found to be not feasible to recruit and the study target population was expanded to include older community dwelling adults with pneumonia, chronic obstructive pulmonary disease (COPD), or hyperkyphosis.

Study Overview

Detailed Description

This original study was a feasibility study to determine the ability to recruit and to assess pilot data to determine the effects of a physical therapy intervention on physical function, gait, balance, posture, pulmonary function, and quality of life. Additionally the 30 day readmission, ER visits, and mortality was to be tracked. This study failed due to lack of recruitment. However, the aim to examine the effectiveness a physical therapy intervention was still used just in a broader population. The intervention and measures remained the same except for 30 day admission/mortality data.

The new aim was to examine the effectiveness of manual therapy and exercise on posture, function, gait, pulmonary function, and quality of life in older community dwelling adults with hyperkyphosis or forward head posture. Kyphosis, osteoporosis, decreased trunk flexibility, and pain are considered potential causes of restrictive lung function. The physical therapy intervention targets both soft tissue and skeletal restrictions to improve mobility. The outcomes were chosen to examine not only the direct impact on posture but also the indirect impact on physical function including pulmonary status. Lastly, cognitive mapping was used to record the change in the perceptions of the participants as they improved.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Galveston, Texas, United States, 77555-1144
        • School of Health Professions at the University of Texas Medical Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • at least 50 years of age
  • hyperkyphosis, forward head posture, pneumonia, or chronic obstructive pulmonary disease (COPD)
  • community dwelling
  • self report of ability to walk 10 feet or greater with or without an assistive device
  • ability to perform informed consent
  • ability to transport to research facility
  • ability to read and write in English or Spanish

Exclusion Criteria:

  • Inability to perform informed consent
  • Inability to follow directions
  • Inability to perform transfers, sit, and stand independently
  • Inability to ambulate 10 feet or more with or without an assistive device
  • Inability to perform pulmonary function testing
  • Inability to fully participate in testing and measures
  • Inability to fully participate in the intervention
  • Severe claustrophobia
  • Unable to tolerate physical touch
  • Morbid obesity (BMI greater than 40)
  • History of prior lung disease such as cancer or transplant
  • History of comorbidity that would affect lung function such as neuromuscular disease (ALS, MS), collagen disease (SLE), cardiovascular disease (CHF), or musculoskeletal disease with an autoimmune component (Ankylosing Spondylosis, RA).
  • A prior discharge within 30 days of hospitalization for pneumonia or COPD
  • Discharge against medical advice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Manual therapy and exercise

The intervention (3 times a week for 4 weeks, for a total of 12 sessions) consisted primarily of manual therapy (soft tissue and joint mobilization) followed by therapeutic exercises (muscular control and coordination).

Manual therapy:

Joint mobilizations (Grades I-V) to cervical spine, thoracic spine and ribs Soft tissue mobilization to the pectoralis, scaleni, upper traps, thoracolumbar fascia, erector spinae, and suboccipital musculature

Therapeutic exercises:

Strengthening of mid and lower traps, lats, glut med, and glut max. Active & passive stretching of thoracic and lumbar rotation, hip flexors, and plantarflexors.

The treating therapists agreed on a protocol with treatment individualized to each patient.

Manual therapy consisting of soft tissue and joint mobilization to gain mobility. Therapeutic exercise was active motion and resisted motion to gain motor control and motor coordination in the new range.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posture, as measured by change in height
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Height in cm
through study completion (4 weeks) and one time follow-up at an average of 6 months
Posture, as measured by change in kyphotic index
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
kyphotic index = (thoracic width/thoracic height) *100 as measured from flexicurve tracing. A flexible ruler is molded to the posterior spine from C7 to the lumbosacral interspace. Ruler is placed on paper and traced. Measures of the thoracic width and height are taken in centimeters.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Posture, as measured by change in block test
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
height of blocks (measured in cm) under the head with participant supine
through study completion (4 weeks) and one time follow-up at an average of 6 months
Posture, visual change in digital photos
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Digital photo in standing anterior and side views as well as supine view
through study completion (4 weeks) and one time follow-up at an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Function as a change in Timed Up and Go speed
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Timed Up and Go as measured in seconds to performed standardized functional test. Participants are timed in seconds from sitting in a chair to standing, walking 3 meters, turning around, walking back, and sitting down.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Function as a change in Functional Reach test
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Functional reach as measured in cm. It is performed by having the participant standing still and is instructed to reach forward as far as you can without taking a step.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Function as a change in the Short Physical Performance Battery (SPPB) score
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
SPPB score as determined by seconds to perform each component of this standardized test. This functional test has 3 components of 5 times sit to stand, gait speed, and balance. 5 times sit to stand is a standardized test of lower extremity strength that is performed by rising and sitting in a chair 5 times in a row. The activity is timed. Gait speed will be extracted from gaitrite data. Balance tests will be timed.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Function and Gait as a change in the 2 Minute Walk Test (2MWT)
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
2MWT is the measured as the distance (feet) covered in 2 minutes
through study completion (4 weeks) and one time follow-up at an average of 6 months
Function and patient perception as change in the Patient Specific Functional Scale (PSFS)
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
PSFS is a standardized survey of activities that are difficult to perform (listed by participant) and to what degree as measured on a likert scale (0 to 10)
through study completion (4 weeks) and one time follow-up at an average of 6 months
Gait as measured by change in gait parameters on a Gaitrite walkway
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
The gaitrite records a standard set of parameters. Change in gait speed (m/sec), step length (cm), stride length (cm), double limb support time (seconds), and step width (cm)
through study completion (4 weeks) and one time follow-up at an average of 6 months
Gait as measured by change in Tekscan measures of force
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Tekscan records a standard set of measures of time and force. Change in peak force at loading response, mid-stance, and terminal stance in newtons.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Pulmonary function change measure by spirometry
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Spirometry provides standard measures of respiratory volume and volume in time. Changes in Forced Vital Capacity and Forced Expiratory Volume in 1 second were the measures of interest.
through study completion (4 weeks) and one time follow-up at an average of 6 months
Patient perception as measured by changes in Cognitive Mapping
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
Cognitive mapping provides the issues, concerns, and perceptions of the participants of how posture affects their life. Measured by words recorded and qualitative analysis.
through study completion (4 weeks) and one time follow-up at an average of 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: through study completion (4 weeks) and one time follow-up at an average of 6 months
measured in pounds
through study completion (4 weeks) and one time follow-up at an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lynne C Hughes, PhD, PT, University of Texas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2018

Primary Completion (Actual)

April 18, 2019

Study Completion (Actual)

December 20, 2019

Study Registration Dates

First Submitted

September 16, 2019

First Submitted That Met QC Criteria

October 1, 2019

First Posted (Actual)

October 3, 2019

Study Record Updates

Last Update Posted (Actual)

February 5, 2020

Last Update Submitted That Met QC Criteria

February 3, 2020

Last Verified

August 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Clinical Trials on Manual therapy and exercise

3
Subscribe